SCHEMBL21188697

SCHEMBL21188697

N#Cc1cccc(-c2cc(-n3c4ccccc4c4ccccc43)cc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccccc6)c5c43)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ADORA2A P29274 2/20 0.38
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 3/20 0.38
GABRA3 P34903 3/20 0.38
GABRA1 P14867 1/20 0.38
PGR P06401 1/20 0.37
CFTR P13569 1/20 0.37
ALDH1A3 P47895 1/20 0.37
CYP1A2 P05177 7/20 0.36
CYP3A4 P08684 6/20 0.36
ALDH1A1 P00352 5/20 0.36
LMNA P02545 5/20 0.36
CLK4 Q9HAZ1 5/20 0.36
CYP2D6 P10635 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21188690 0.92 KDM4E (0.39) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL21546486 0.91 KDM4E (0.42) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL21189077 0.90 KDM4E (0.46) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL17721908 0.90 KDM4E (0.42) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL21188692 0.89 KDM4E (0.45) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL26473186 0.89 KDM4E (0.38) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL17721927 0.88 ADORA2A (0.41) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL13196230 0.88 ADORA2A (0.41) KDM4EATML3MBTL1ADORA2AGABRG2
SCHEMBL19702239 0.88 KDM4E (0.44) KDM4EATML3MBTL1ADORA2APGR
SCHEMBL19711256 0.88 KDM4E (0.44) KDM4EATML3MBTL1ADORA2APGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190229276-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190229276-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNT1, CCND2 KDM4E 3333/4885ATM 607/4885L3MBTL1 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.